2023
DOI: 10.1093/nar/gkad727
|View full text |Cite
|
Sign up to set email alerts
|

Novobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity

Aleem Syed,
Frantisek Filandr,
Jeffrey Patterson-Fortin
et al.

Abstract: Polymerase theta (Polθ) acts in DNA replication and repair, and its inhibition is synthetic lethal in BRCA1 and BRCA2-deficient tumor cells. Novobiocin (NVB) is a first-in-class inhibitor of the Polθ ATPase activity, and it is currently being tested in clinical trials as an anti-cancer drug. Here, we investigated the molecular mechanism of NVB-mediated Polθ inhibition. Using hydrogen deuterium exchange-mass spectrometry (HX-MS), biophysical, biochemical, computational and cellular assays, we found NVB is a non… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 86 publications
0
7
0
Order By: Relevance
“…To test this automation approach, we applied it to a manually curated dataset collected in DIA mode but analyzed in the conventional MS 1 -only fashion 39 . Pol ϴ, a DNA polymerase, is a cancer drug target.…”
Section: Resultsmentioning
confidence: 99%
“…To test this automation approach, we applied it to a manually curated dataset collected in DIA mode but analyzed in the conventional MS 1 -only fashion 39 . Pol ϴ, a DNA polymerase, is a cancer drug target.…”
Section: Resultsmentioning
confidence: 99%
“…However, as the compound equally affects the control Firefly luciferase signal, we cannot conclude that the effect is specific and possibly highlights its potentially promiscuous pharmacology ( 46 ). Modulation of Polθ-mediated MMEJ by novobiocin may however reflect a more complicated mechanism of action not captured in the extrachromosomal assay format ( 48 ) and/or one that is revealed in a different context such as a chromosomally integrated MMEJ reporter system ( 45 ).…”
Section: Discussionmentioning
confidence: 99%
“…Asynchronous POLQ -/-HF1 and HCT116 cells each showed a reproducible, significant, but partial loss of deletions as well as other types of SVs relative to wild-type (Figures 5D, 5E, S9A and S9B). Deletion SV reduction was again partial in HCT116 asynchronous or M-phase cells treated with the POLQ inhibitors ART558 48 or novobiocin (NVB) 49,50 (Figures 5E and 5F). In contrast, APH-treated POLQ -/-HCT116 Mphase cells showed baseline levels of SV formation with no apparent induction by APH (Figures 5F and S9C).…”
Section: Chemical Polq Inhibition and Polq Knockout Differentially Im...mentioning
confidence: 99%